Not known Facts About WST-8
Stay clear of coadministration of pazopanib with potent CYP3A4 inhibitors if possible; if should coadminister, lessen pazopanib dose to 400 mg/dayMinor (one)dasatinib and pazopanib both equally enhance QTc interval. Minor/Significance Unknown.Serious - Use Substitute (1)aluminum hydroxide/magnesium trisilicate will lessen the level or impact of paz